Technology
Health
Pharmaceutical
Sutro Biopharma
$10.919876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.48 (-4.21%) Today
-$0.48 (-4.21%) Today
Why Robinhood?
You can buy or sell STRO and other stocks, options, ETFs, and crypto commission-free!
About
Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. Its products technologies include XpressCF; anti-body drug conjugates; bispecifics and engineered antibodies; and cGMP facility. Read More The company was founded in June 2003 and is headquartered in South San Francisco, CA.
Employees
—
Headquarters
South San Francisco, California
Founded
2003
Market Cap
260.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
71.28K
High Today
$10.91
Low Today
$10.91
Open Price
$10.91
Volume
1.41K
52 Week High
$15.90
52 Week Low
$8.50
Collections
Technology
Health
Pharmaceutical
Manufacturing
2018 IPO
US
North America
News
PR NewswireMar 5
Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 5, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11 at 2:50 p.m. ET at the Marriott Copley Place in Boston. A live webcast of the presentation will be accessible through the Events and Presentations page of the Investor Relations section of the company's website at www.sutrobio.com. A replay of the webcast will be...
Price Paid on Robinhood
16% Higher
Right Now
52 Week Low
$8.50
Average Price Paid
$9.41
52 Week High
$15.90
Earnings
-$21.26
-$14.23
-$7.19
-$0.16
Q3 2018
Q4 2018
Estimated
-$0.63 per share
Actual
Expected Today, After Hours